Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and i… Read more
Pharmaniaga Bhd (7081) - Total Liabilities
Latest total liabilities as of December 2025: RM1.79 Billion MYR
Based on the latest financial reports, Pharmaniaga Bhd (7081) has total liabilities worth RM1.79 Billion MYR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmaniaga Bhd - Total Liabilities Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pharmaniaga Bhd Competitors by Total Liabilities
The table below lists competitors of Pharmaniaga Bhd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MORELD AS
OL:MORLD
|
Norway | Nkr6.01 Billion |
|
United Bankers Oyj
HE:UNITED
|
Finland | €38.51 Million |
|
KPS Corporation
KQ:256940
|
Korea | ₩123.69 Billion |
|
Cosmo Electronics Corp
TW:2466
|
Taiwan | NT$2.23 Billion |
|
iClick Interactive Asia Group
NASDAQ:ICLK
|
USA | $122.45 Million |
|
Sandhar Technologies Limited
NSE:SANDHAR
|
India | ₹19.74 Billion |
|
DACHA STRATEGIC
F:7DC
|
Germany | €7.18 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Pharmaniaga Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmaniaga Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmaniaga Bhd (2012–2025)
The table below shows the annual total liabilities of Pharmaniaga Bhd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | RM1.79 Billion | -16.40% |
| 2024-12-31 | RM2.14 Billion | -2.32% |
| 2023-12-31 | RM2.19 Billion | -0.30% |
| 2022-12-31 | RM2.20 Billion | +22.84% |
| 2021-12-31 | RM1.79 Billion | +43.84% |
| 2020-12-31 | RM1.24 Billion | -0.94% |
| 2019-12-31 | RM1.25 Billion | -10.29% |
| 2018-12-31 | RM1.40 Billion | +29.52% |
| 2017-12-31 | RM1.08 Billion | -6.31% |
| 2016-12-31 | RM1.15 Billion | +23.13% |
| 2015-12-31 | RM936.00 Million | +35.46% |
| 2014-12-31 | RM691.00 Million | +13.65% |
| 2013-12-31 | RM608.00 Million | -17.28% |
| 2012-12-31 | RM735.00 Million | -- |